Human synovial sarcoma proto-oncogene Syt is essential for early embryonic development through the regulation of cell migration

Laboratory Investigation

Volumn 89, Issue 6, 2009, Pages 645-656

  Kimura, Taichi ^a   Sakai, Mieko ^a   Tabu, Kouichi ^a   Wang, Lei ^a   Tsunematsu, Ryosuke ^b   Tsuda, Masumi ^a   Sawa, Hirofumi ^a,e   Nagashima, Kazuo ^a,f   Nishihara, Hiroshi ^a   Hatakeyama, Shigetsugu ^a   Nakayama, Keiko ^c   Ladanyi, Marc ^d   Tanaka, Shinya ^a,g   Nakayama, Keiichi I ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e HOKKAIDO UNIVERSITY   (Japan)

^f Sapporo Higashi Tokushukai Hospital   (Japan)

^g HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cardiogenesis; Embryonic lethality; Motility; P300; Synovial sarcoma; Syt

Indexed keywords

ACTIN; SYNAPTOTAGMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL MIGRATION; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FIBROBLAST; FIBROBLAST CULTURE; GROWTH RETARDATION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LETHALITY; MIGRATION INHIBITION; MOUSE; NEURAL TUBE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGANIZATION; PHENOTYPE; PLACENTA DISORDER; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTO ONCOGENE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYNOVIAL SARCOMA; SYNOVIAL SARCOMA TRANSLOCATION GENE;

ACTINS; ANIMALS; ANIMALS, NEWBORN; CELL MOVEMENT; CELLS, CULTURED; EMBRYO LOSS; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FEMALE; FIBROBLASTS; HEART DEFECTS, CONGENITAL; HUMANS; MICE; MICE, KNOCKOUT; NEURAL TUBE; PLACENTA; PREGNANCY; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 66549088711     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.25     Document Type: Article

References (34)

1. Ladanyi M. Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene 2001;20:5755-5762.
2. Lewis JJ, Antonescu CR, Leung DH, et al. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol 2000;18:2087-2094.
3. Clark J, Rocques PJ, Crew AJ, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994;7:502-508.
4. dos Santos NR, de Bruijn DR, van Kessel AG. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer 2001;30:1-14.
5. Thaete C, Brett D, Monaghan P, et al. Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and colocalization with the SNF protein BRM in the nucleus. Hum Mol Genet 1999;8:585-591.
6. Brett D, Whitehouse S, Antonson P, et al. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localized in nuclear bodies. Hum Mol Genet 1997;6:1559-1564.
7. Nagai M, Tanaka S, Tsuda M, et al. Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha. Proc Natl Acad Sci USA 2001;98:3843-3848.
8. Kato H, Tjernberg A, Zhang W, et al. SYT associates with human SNF/ SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones. J Biol Chem 2002;277:5498-5505.
9. Ishida M, Tanaka S, Ohki M, et al. Transcriptional co-activator activity of SYT is negatively regulated by BRM and Brg1. Genes Cells 2004;9:419-428.
10. de Bruijn DR, dos Santos NR, Thijssen J, et al. The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10. Oncogene 2001;20:3281-3289.
11. Eid JE, Kung AL, Scully R, et al. p300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion. Cell 2000;102:839-848.
12. Ito T, Ouchida M, Ito S, et al. SYT, a partner of SYT-SSX oncoprotein in synovial sarcomas, interacts with mSin3A, a component of histone deacetylase complex. Lab Invest 2004;84:1484-1490.
13. Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996;85:707-720.
14. Sambrook J, Maniatis T, Fritsch EF. Molecular Cloning. A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory: NY, 1989.
15. Yang JT, Rayburn H, Hynes RO. Embryonic mesodermal defects in a5 integrin-deficient mice. Development 1993;119:1093-1105.
16. Defilippi P, Truffa G, Stefanuto G, et al. Tumor necrosis factor a and interferon g modulate the expression of the vitronectin receptor (integrin h3) in human endothelial cells. J Biol Chem 1991;266: 7638-7645.
17. de Bruijn DR, Peters WJ, Chuva de Sousa Lopes SM, et al. Targeted disruption of the synovial sarcoma-associated SS18 gene causes early embryonic lethality and affects PPARBP expression. Hum Mol Genet 2006;15:2936-2944.
18. Yao TP, Oh SP, Fuchs M, et al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 1998;93:361-372.
19. Gale NW, Dominguez MG, Noguera I, et al. Haploinsufficiency of deltalike 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA 2004;101:15949-15954.
20. Kuhnert F, Campagnolo L, Xiong JW, et al. Dosage-dependent requirement for mouse Vezf1 in vascular system development. Dev Biol 2005;283:140-156.
21. Zhang YM, Bo J, Taffet GE, et al. Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. FASEB J 2006;20:916-925.
22. Cross JC. Genetic insights into trophoblast differentiation and placental morphogenesis. Semin Cell Dev Biol 2000;11:105-113.
23. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet 2001;2:538-548.
24. Hemberger M, Cross JC. Genes governing placental development. Trends Endocrinol Metab 2001;12:162-168.
25. Srivastava D, Olson EN. A genetic blueprint for cardiac development. Nature 2000;407:221-226.
26. Lickert H, Takeuchi JK, Von Both I, et al. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 2004;432:107-112.
27. Wang Z, Zhai W, Richardson JA, et al. Polybromo protein BAF180 functions in mammalian cardiac chamber maturation. Genes Dev 2004;18:3106-3116.
28. Brakebusch C, Fassler R. β1 integrin function in vivo: adhesion, migration and more. Cancer Metastasis Rev 2005;23:403-411.
29. de Rooij J, Zwartkruis FJ, Verheijen MH, et al. Epac is a Rap1 guanine nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998;396:474-477.
30. Kawasaki H, Springett GM, Mochizuki N, et al. A family of cAMP-binding proteins that directly activate Rap1. Science 1998;282:2275-2279.
31. Bos JL. Linking Rap to cell adhesion. Curr Opin Cell Bio 2005;17: 123-128.
32. Gupta M, Yarwood SJ. MAP1A light chain 2 interacts with exchange protein activated by cyclic AMP 1 (EPAC1) to enhance Rap1 GTPase activity and cell adhesion. J Biol Chem 2005;280: 8109-8116.
33. Del Pozo MA, Alderson NB, Kiosses WB, et al. Integrins regulate Rac targeting by internalization of membrane domains. Science 2004;303:839-842.
34. Rangarajan S, Enserink JM, Kuiperij HB, et al. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor. J Cell Biol 2003;160: 487-493.